1. Morita M, Wang HL. Effect of initial periodontal therapy on sulcular/tongue sulfide level. A pilot study. J Clin Periodontol. 2002 29:844-7.
2. Amoo-Achampong F, Vitunac DE, Deeley K, Modesto A, Vieira AR. Complex patterns of response to oral hygiene instructions: longitudinal evaluation of periodontal patients. BMC Oral Health. 2018, 18:72.
3. Tao Q, Young LS, Woodman CB, Murray PG. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci. 2006;11:2672-13.
4. Lin JC, Lin SC, De BK, Chan WP, Evatt BL. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Blood. 1993;81:3372-81.
5. Maeda E, Akahane M, Kiryu S, et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol. 2009;27:4-19.
6. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350:1328-37.
7. Imai K, Inoue H, Tamura M, et al. The periodontal pathogen Porphyromonas gingivalis induces the Epstein-Barr virus lytic switch transactivator ZEBRA by histone modification. Biochimie. 2012;94: 839-46.
8. Imai K, Kamio N, Cueno ME, et al. Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells. FEBS J. 2014;281:2148-58.
9. Timms JM, Bell A, Flavell JR, et al. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet. 2003;361:217-23.
10. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22:883-96.
11. Lai KY, Chou YC, Lin JH, et al. Maintenance of Epstein-Barr virus latent status by a novel mechanism, latent membrane protein 1-induced interleukin-32, via the protein kinase Cδ pathway. J Virol. 2015;89:5968-80.
12. D'Addario M, Libermann TA, Xu J, Ahmad A, Menezes J. Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways. J Mol Biol. 2001;308:501-14.
13. Slots J, Saygun I, Sabeti M, Kubar A. Epstein-Barr virus in oral diseases. J Periodontal Res. 2006;41:235-44.
14. Corstjens PL, Abrams WR, Malamud D. Saliva and viral infections. Periodontol 2000. 2016;70:93-110.
15. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect. 2000;2:115-20.
16. Kamma JJ, Contreras A, Slots J. Herpes viruses and periodontopathic bacteria in early-onset periodontitis. J Clin Periodontol. 2001;28:879-85.
17. Slots J, Kamma JJ, Sugar C. The herpesvirus-Porphyromonas gingivalis -periodontitis axis. J Periodontal Res. 2003;38:318-23.
18. Kato A, Imai K, Ochiai K, Ogata Y. Higher prevalence of Epstein-Barr virus DNA in deeper periodontal pockets of chronic periodontitis in Japanese patients. PLoS One. 2013;8(8): e71990.
19. Kato A, Imai K, Ochiai K, Ogata Y. Prevalence and quantitative analysis of Epstein-Barr virus DNA and Porphyromonas gingivalis associated with Japanese periodontitis patients. Clin Oral Investig. 2015;19:1605-10.
20. Zhu C, Li F, Wong MC, Feng XP, Lu HX, Xu W. Association between Herpesviruses and Chronic Periodontitis: A Meta-Analysis Based on Case-Control Studies. PLoS One. 2015;10:e0144319.
21. Lu H, Zhu C, Li F, Xu W, Tao D, Feng X. Putative periodontopathic bacteria and herpesviruses in pregnant women: a case-control study. Sci Rep. 2016;6:27796.
22. Ogata Y, Nakayama Y, Tatsumi J, et al. Prevalence and risk factors for peri-implant diseases in Japanese adult dental patients. J Oral Sci. 2017;59:1-11.
23. Berglundh T, Gislason O, Lekholm U, Sennerby L, Lindhe, J. Histopathological observations of human periimplantitis lesions. J Clin Periodontol. 2004;31:341-7.
24. Carcuac O, Berglundh T. Composition of human peri-implantitis and periodontitis lesions. J Dent Res. 2014;93:1083-8.
25. Shiba T, Watanabe T, Kachi H, Koyanagi T, Maruyama N, Murase K, Takeuchi Y, Maruyama F, Izumi Y, Nakagawa I. Distinct interacting core taxa in co-occurrence networks enable discrimination of polymicrobial oral diseases with similar symptoms. Sci Rep. 2016;6:30997.
26. Kato A, Imai K, Sato H, Ogata Y. Prevalence of Epstein-Barr virus DNA and Porphyromonas gingivalis in Japanese peri-implantitis patients. BMC Oral Health. 2017 17:148.
27. Takada K, Horinouchi K, Ono Y, et al. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes. 1991;5:147–56.
28. Watanabe T, Maruyama F, Nozawa T, et al. Complete genome sequence of the bacterium Porphyromonas gingivalis TDC60, which causes periodontal disease. J Bacteriol. 2011;193:4259-60.
29. Slots J. Human viruses in periodontitis. Periodontol 2000. 2010; 53;89-110.
30. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol. 1984;11:21-32.
31. Chalabi M, Rezaie F, Moghim S, Mogharehabed A, Rezaei M, Mehraban B. Periodontopathic bacteria and herpesviruses in chronic periodontitis. Mol Oral Micobiol. 2010;25:236-40.
32. Özcan E, Saygun NI, Serdar MA, Kubar A, Bengi VU. Porphyromonas gingivalis and Epstein-Barr Virus are associated with increased levels of visfatin in gingival crevicular fluid. J Periodontol. 2016;87:443-51.
33. Saygun I, Kubar A, Ozdemir A, Yapar M, Slots J. Herpesviral-bacterial interrelationships in aggressive periodontitis. J Periodontal Res. 2004;39:207-212
34. Saygun I, Kubar A, Sahin S, Sener K, Slots J. Quantitative analysis of association between herpesviruses and bacterial pathogens in periodontitis. J Periodont Res. 2008;43:352-359.
35. Slots J. Herpesviral-bacterial interactions in periodontal diseases. Periodontol 2000. 2010;52:117-40.
36. Verdugo F, Castillo A, Castillo F, Uribarri A. Epstein-Barr virus associated peri-implantitis: a split-mouth study. Clin Oral Investig. 2015;19:535-43.